Labcorp stock trades near recent highs after revenue growth and Q1 2026 update
Published on 09/20/2026 at 15:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Labcorp Holdings Inc. stock (ISIN US50540R4092) is trading around a reference level in the low USD 320s on the New York Stock Exchange as of mid-September 2026, keeping the shares close to recent highs against a backdrop of solid revenue growth in first-quarter 2026. As of September 19, 2026, an overview of Labcorp Holdings share data shows a closing price of USD 322.18 with the stock touching an intraday high of USD 329.46 and a low of USD 322.59 during that session, highlighting a relatively tight trading range at an elevated level.
Revenue grows in Q1 2026
According to a first-quarter 2026 filing summary for Labcorp Holdings Inc., the company reported Q1 2026 revenues of USD 3,537.6 million, an increase of 5.8 percent compared with Q1 2025, driven by 3.1 percent organic growth, acquisitions and favorable currency effects.StockTitan This Q1 2026 revenue level compares with approximately USD 3,537 million in the same period a year earlier, illustrating a modest but tangible expansion in the company’s top line as it continues to grow its diagnostics and laboratory services portfolio.
A multi-period revenue overview for Labcorp shows that quarterly revenue has been trending upward, with figures rising from about USD 3,345 million in Q1 2025 to around USD 3,731 million by Q2 2026, underscoring that the Q1 2026 increase is part of a broader multi-quarter growth pattern.INDmoney For investors, the fact that revenue grew by 5.8 percent in Q1 2026 while maintaining organic growth above 3 percent is a key data point, indicating that Labcorp is expanding both through its core operations and through portfolio additions.
Stock holds near recent highs
Recent quote data for Labcorp Holdings indicates that the stock is trading in the USD 320 to USD 329 band, near reference highs seen during mid-September 2026, suggesting that the market has largely priced in the latest revenue improvement and continues to value the company’s diagnostics franchise at a premium level.INDmoney As of September 19, 2026, Labcorp Holdings’ share price of USD 322.18 is only a few dollars below the day’s high of USD 329.46, pointing to limited intraday volatility and continued investor confidence at these levels.
Additional sector data show that Labcorp, with its multi-billion-dollar quarterly revenue base, competes in the broader healthcare diagnostics and laboratory services space alongside other major players, and its 5.8 percent year-on-year revenue increase in Q1 2026 positions the company as a steady growth name rather than a high-volatility outlier.StockTitan For shareholders, the combination of a stable trading band around USD 320 and a clear quantified revenue improvement offers a balanced picture: upside from operational growth, but at valuation levels that already reflect much of the company’s execution.
Price level and investor perspective
Based on the most recent available closing quote of USD 322.18 on the New York Stock Exchange as of September 19, 2026, Labcorp stock remains near its recent intraday high of USD 329.46, with the Q1 2026 revenue increase of 5.8 percent versus 2025 providing fundamental support for the current valuation.
Labcorp stock key data
- Company: Labcorp Holdings Inc.
- ISIN: US50540R4092
- Ticker: LH
- Trading venue: NYSE
- Price (as of September 19, 2026, 16:00): 322.18 USD
- Market capitalization: 26,010,000,000 USD (as of September 19, 2026)
- Sector / Industry: Healthcare diagnostics and laboratory services
- Index membership: S&P 500
